Astellas Pharma Inc.

Company NameAstellas Pharma Inc.
PI Number19
Revenue (Millions)$12,327
Total Equity (Millions)$14,630
Net Income (Millions)$874
Revenue Growth(2.15%)
Profit Margin 17.09%
Earnings per Share$1.89
Debt to Equity RatioN/A
Return on Equity6.03%
Cost of Goods Sold (Millions)$3,825
Earnings per Share Growth(44.07%)
Total Assets (Millions)$17,252
Current Liabilities (Millions)$4,057
Long Term Debt (Millions)N/A